恒瑞医药：硫酸艾玛昔替尼片等两款产品临床试验获批

Core Viewpoint - Heng Rui Medicine announced the approval of clinical trial notifications for Sulfate Emamectin Benzoate Tablets and SHR0302 Gel by the National Medical Products Administration, aimed at treating vitiligo [1] Group 1 - The company and its subsidiary, Ruishi Biopharmaceutical Co., Ltd., received approval for clinical trials [1] - The approved indications include the use of Sulfate Emamectin Benzoate Tablets alone or in combination with SHR0302 Gel for the treatment of vitiligo [1]